Beiersdorf
This article was originally published in The Rose Sheet
Executive Summary
Skin care brands Onagrine and Nobacter acquired from Boots for $28.6 mil. (FF1=$.13). Purchases represent Beiersdorf's foray into French pharmaceutical skin care market, German company says. Onagrine and Nobacter products will continue to be manufactured by Boots in Chace, France while 27 employees in product development, marketing and sales will transition to Beiersdorf. Firm has no plans to expand brand distribution outside France, Beiersdorf says. Boots, which acquired brands in 1990s to achieve critical mass in French skin care market, will record loss of $12.7 mil. ([L]1=$1.41) for sale, UK retailer/marketer says. Core skin care focus has moved to dermatitis and acne since firm acquired Clearasil from Procter & Gamble last year for $340 mil. (1"The Rose Sheet" Oct. 23, 2000, p. 3)